home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

The EU Clinical Trial Directive

  July 13, 2015  
Center for Professional Innovation & Education, Inc., Malvern, PA
November 9 & 10, 2015

This course focuses on understanding and implementing the requirements of the EU Clinical Trial Directive. The course covers all relevant topics associated with the Directive, and a review of methods for effective implementation. The course consists of lecture and interactive exercises to re-enforce the learning.

Key topics to be discussed:

  • The current regulatory situation in relation to clinical trials in the European Union
  • The purpose of the new Clinical Trial Directive
  • Implementing the EU clinical trial requirements
  • The impact the Directive will have on running clinical trials
  • The key differences between the EU Clinical Trials Directive, FDA Regulations and ICH Guidelines
Organized by: Center for Professional Innovation & Education
Invited Speakers:

Michael A. Pierro

Specialties: Regulatory, International

Michael A. Pierro is consultant to life sciences industries; building on over 35 years of pharmaceutical-industry experience to provide services in clinical-practice areas of SOPs, study management and monitoring, auditing and site qualification.

Mr. Pierro previously served as Director of Business Development, Consulting and Clinical Training for a large consulting firm. There, he was responsible for the development and implementation of SOPs, specialized training programs and related consulting services. His clients included pharmaceutical and biotechnology firms, CROs, university medical centers and the United States government.

Before this, Mr. Pierro was Director of Global Training for the Global Clinical Quality Assurance Department of Hoechst Marion Roussel (now Aventis). In this role, he directed all GCP, SOP and technical training activities within the company’s Drug Development Center and other sites throughout the world. In his other roles at the company; he served as a Senior CRA, Manager of Phase-IV Clinical Operations, Chairperson of the SOP Steering Committee and GCP Auditor. In addition, Mr. Pierro was involved in several NDA/SNDA preparations, filings and other reports to regulatory agencies. 

Deadline for Abstracts: n/a
E-mail: info@cfpie.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.